Open access · OA
via Europe PMC
Ferro-aging: a potential driver of degenerative bone and joint diseases.
Liang S, Gao S, Wang F, Qu X, Kong L, Wang C, Li N.
Cell communication and signaling : CCS · 2026
Cellular senescence
Altered intercellular communication
Chronic inflammation
Partial reprogramming (OSK)
Human
Review
Abstract
Degenerative bone and joint diseases (DBJDs), including osteoporosis (OP), osteoarthritis (OA), and intervertebral disc degeneration (IVDD), are chronic age-related disorders characterized by progressive destruction of bone and joint tissues and loss of function, posing a heavy global health burden. Emerging evidence indicates that iron dyshomeostasis, chronic lipid peroxidation, and cellular senescence(definition) are common pathological features shared by these diseases. The newly discovered concept of ferro-aging-a non-lethal, persistent cellular state driven by sub-lethal lipid peroxidation that leads to cellular dysfunction and a senescence-associated secretory phenotype (SASP)-provides a unified mechanistic framework linking iron metabolism to age-related degeneration. This review systematically summarizes the molecular basis of ferro-aging, with a focus on the central role of ACSL4 in promoting membrane lipid remodeling and sustaining chronic lipid peroxidation. We discuss how ACSL4-associated ferro-aging contributes to the pathogenesis of OP, OA, and IVDD by disrupting local microenvironmental homeostasis, driving metabolic reprogramming, amplifying inflammatory SASP signaling, and impairing the function of key cell types such as osteoblasts (OBs), chondrocytes, and nucleus pulposus cells (NPCs). The differential response to the same ferro-aging program across different tissues determines the distinct clinical phenotypes of these diseases. Finally, we highlight potential intervention strategies targeting the ACSL4-ferro-aging axis and future research directions, offering new insights for the precision treatment of degenerative bone and joint diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1186/s12964-026-03194-3
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
S, L., S, G., F, W., X, Q., L, K., C, W., & N., L. (2026). Ferro-aging: a potential driver of degenerative bone and joint diseases. <em>Cell communication and signaling : CCS</em>. https://doi.org/10.1186/s12964-026-03194-3
Vancouver
S L, S G, F W, X Q, L K, C W, et al. Ferro-aging: a potential driver of degenerative bone and joint diseases. Cell communication and signaling : CCS. 2026. doi:10.1186/s12964-026-03194-3.
BibTeX
@article{liang2026Ferroa,
title = {Ferro-aging: a potential driver of degenerative bone and joint diseases.},
author = {Liang S and Gao S and Wang F and Qu X and Kong L and Wang C and Li N.},
journal = {Cell communication and signaling : CCS},
year = {2026},
doi = {10.1186/s12964-026-03194-3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bone Research 2025
Open access · CC-BY
Cellular senescence and other age-related mechanisms in skeletal diseases
Cellular & Molecular Biology Letters 2023
Open access · CC-BY
Cellular senescence in skeletal disease: mechanisms and treatment
Bone Research 2024
Open access · CC-BY
Cross-talk of inflammation and cellular senescence: a new insight into the occurrence and progression of osteoarthritis
Ageing Research Reviews 2024
Citation only
Lipids and lipid metabolism in cellular senescence: Emerging targets for age-related diseases
Antioxidants 2025
Open access · CC-BY
Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons
npj Aging 2026
Open access · CC-BY